Unknown

Dataset Information

0

Low serum neutralization of Omicron variants a month after AZD7442 prophylaxis initiation.

ABSTRACT:

SUBMITTER: de Lamballerie X 

PROVIDER: S-EPMC9546501 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Molecular Characterization of AZD7442 (Tixagevimab-Cilgavimab) Neutralization of SARS-CoV-2 Omicron Subvariants.
| S-EPMC10100701 | biostudies-literature
Unknown Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies.
| S-EPMC9906471 | biostudies-literature
Unknown Neutralization, effector function and immune imprinting of Omicron variants.
| S-EPMC10511321 | biostudies-literature
Unknown Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron and Other Variants in Serum From Children With Vaccination-Induced Myocarditis.
| S-EPMC9047211 | biostudies-literature
Unknown Effectiveness of AZD7442 (Tixagevimab/Cilgavimab) for Pre-Exposure Prophylaxis Against COVID-19 Hospitalization in Israel During the Omicron Sub-Variant Time Period.
| S-EPMC11829863 | biostudies-literature
Unknown Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays.
| S-EPMC8906917 | biostudies-literature
Unknown Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants.
| S-EPMC9231177 | biostudies-literature
Unknown SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons.
| S-EPMC8781314 | biostudies-literature
Unknown Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants.
| S-EPMC9006770 | biostudies-literature
Unknown Differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab-cilgavimab.
| S-EPMC10076000 | biostudies-literature